Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Investig Med High Impact Case Rep ; 2(2): 2324709614531556, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-26425603

RESUMO

The recent increase in heterotopic pregnancies has been largely attributed to the increased use of assisted reproduction technologies. We report the rare case of a multiparous woman with a spontaneous conception resulting in a triplet heterotopic pregnancy: a twin intrauterine pregnancy and a single right tubal ectopic pregnancy. Heterotopic pregnancy is a rare and potentially life-threatening condition in which simultaneous gestations occur at 2 or more implantation sites. It is infrequent in natural conception cycles, occurring in 1:30 000 pregnancies. However, the prevalence is rising with the increased use of assisted reproduction techniques to that of 1:100 to 1:500 in these patient subgroups, highlighting the need to incorporate it into a clinician's diagnostic algorithm.

2.
Int J STD AIDS ; 17(9): 579-84; quiz 585-7, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16942648

RESUMO

The high prevalence of abnormal cervical cytology in the context of immunosuppression has been recognized for many years. In response to repeated observations of cervical cancers in HIV-infected women, moderate and severe cervical dysplasia were designated as early symptomatic HIV infection (Category B) by the Centers for Disease Control and Prevention (CDC) in 1993, and invasive cervical cancer as an AIDS-defining condition (Category C). HIV-infected women, therefore, differ from the general population not only with a greater risk for more, but also potentially more severe cervical disease. In the era of highly active antiretroviral therapy, with HIV-infected women living for longer, there is a clear need to address this increased risk with appropriate management guidelines which this review attempts to provide.


Assuntos
Terapia Antirretroviral de Alta Atividade , Infecções por HIV/complicações , Programas de Rastreamento , Displasia do Colo do Útero/complicações , Neoplasias do Colo do Útero/complicações , Feminino , Fluoruracila/uso terapêutico , Seguimentos , Previsões , Infecções por HIV/tratamento farmacológico , Soropositividade para HIV/complicações , Humanos , Programas de Rastreamento/métodos , Prevalência , Neoplasias do Colo do Útero/epidemiologia , Neoplasias do Colo do Útero/terapia , Displasia do Colo do Útero/epidemiologia , Displasia do Colo do Útero/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA